NASDAQ:GRCL
Gracell Biotechnologies Inc.
- Stock
locale
China
market
STOCKSindustry
Biotechnologywebsite
www.gracellbio.comipo date
Jan 08, 2021
Gracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, primarily discovers and develops cell therapies for the treatment of cancer in the People's Republic of China. Its lead product candidates include GC012F, a FasTCAR-enabled dual BCMA- and CD19-directed autologous CAR-T product candidate that is in Phase I trial for the treatment of multiple myeloma; GC019...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus